2023: A year of accomplishments for the 13 Science Citation Index Expanded- and Emerging Sources Citation Index-indexed Baishideng journals

Abstract

In 2023, Baishideng Publishing Group (Baishideng) routinely published 47 open-access journals, including 46 English-language journals and 1 Chinese-language journal. Our successes were accomplished through the collective dedicated efforts of Baishideng staffs, Editorial Board Members, and Peer Reviewers. Among these 47 Baishideng journals, 7 are included in the Science Citation Index Expanded (SCIE) and 6 in the Emerging Sources Citation Index (ESCI). With the support of Baishideng authors, company staffs, Editorial Board Members, and Peer Reviewers, the publication work of 2023 is about to be successfully completed. This editorial summarizes the 2023 activities and accomplishments of the 13 SCIE- and ESCI-indexed Baishideng journals, outlines the Baishideng publishing policy changes and additions made this year, and highlights the unique advantages of Baishideng journals.

Key Words: Baishideng Publishing Group, Journal Impact Factor, Open access, Policy changes, Policy additions, Unique advantages, Anxiety disorders, Colorectal cancer, Inflammatory bowel disease, Hepatocellular carcinoma, Gut microbes, Atrial fibrillation

Core Tip: With the support of Baishideng Publishing Group (Baishideng) authors, company staffs, Editorial Board Members, and Peer Reviewers, the publication work of our 47 open-access journals in 2023 is about to be successfully completed. This editorial summarizes the 2023 activities and accomplishments of the 13 Baishideng journals indexed in Science Citation Index Expanded and Emerging Sources Citation Index, outlines the Baishideng publishing policy changes and additions made this year, and highlights the unique advantages of Baishideng journals.

INTRODUCTION

In 2023, Baishideng Publishing Group (Baishideng) routinely published 47 open-access journals, including 46 English-language journals and 1 Chinese-language journal. Among these, 7 are included in the Science Citation Index Expanded (SCIE) and 6 in the Emerging Sources Citation Index (ESCI). With the support and dedication of all Baishideng staffs, Editorial Board Members, and Peer Reviewers, the publication work of these 13 journals in 2023 is about to be successfully completed.

BRIEF SUMMARY FOR THE 13 SCIE- AND ESCI-INDEXED BAISHIDENG JOURNALS IN 2023

Number of manuscripts received and published

As of December 20, 2023, the 13 SCIE- and ESCI-indexed Baishideng journals received a total of 5726 manuscript submissions, of which 2533 (44.2%) passed peer review and were published online (Figure 1). Among those, the World Journal of Gastroenterology received 1602 manuscript submissions and published 428 articles, with 827 (51.6%) having been rejected and 360 (22.5%) still under peer review.

Figure 1 Rate of publication with respect to the total number of submissions for the 13 Baishideng journals indexed in Science Citation Index Expanded and Emerging Sources Citation Index.

The 2533 articles published in the collective Baishideng journals have already garnered a total of 1330 citations, accounted for by 681 (26.9%) of those articles. An outstanding accomplishment has been achieved by 45 (1.8%) of those articles having received more than 5 citations each and 10 (0.4%)[1-10] having been cited more than 10 times in the current year (Table 1).

Table 1 Articles published in 2023 in the 13 Baishideng journals indexed in Science Citation Index Expanded and Emerging Sources Citation Index cited more than 5 times in the current year.

No.	DOI	Article title	Journal title	Volume and issue	Article type	Times cited	Total article views	PDF downloads
1	10.12998/wjcc.v11.i7.1442	Risk factors and digital interventions for anxiety disorders in college students: Stakeholder perspectives	World Journal of Clinical Cases	Volume 11 issue 7	Review	22	2747	161
2	10.3748/wjg.v29.i8.1289	Early-onset colorectal cancer: A review of current knowledge	World Journal of Gastroenterology	Volume 29 issue 8	Review	20	4085	284
3	10.3748/wjg.v29.i14.2078	Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives	World Journal of Gastroenterology	Volume 29 issue 14	Review	16	4810	331
4	10.3748/wjg.v29.i8.1243	Predictors of early and late hepatocellular carcinoma recurrence	World Journal of Gastroenterology	Volume 29 issue 8	Review	12	3549	212
5	10.3748/wjg.v29.i28.4368	Microbiota revolution: How gut microbes regulate our lives	World Journal of Gastroenterology	Volume 29 issue 28	Review	11	2921	85
6	10.4330/wjc.v15.i5.229	Atrial fibrillation and coronary artery disease: An integrative review focusing on therapeutic implications of this relationship	World Journal of Cardiology	Volume 15 issue 5	Minireviews	10	2173	316
7	10.4239/wjd.v14.i3.130	Pancreatic β-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress	World Journal of Diabetes	Volume 14 issue 3	Review	10	3130	214
8	10.4239/wjd.v14.i2.62	Modulatory effect of caffeic acid in alleviating diabetes and associated complications	World Journal of Diabetes	Volume 14 issue 2	Review	10	3041	205
9	10.3748/wjg.v29.i15.2272	Intestinal ultrasound as a non-invasive tool to monitor inflammatory bowel disease activity and guide clinical decision making	World Journal of Gastroenterology	Volume 29 issue 15	Minireviews	10	4090	197
10	10.5312/wjo.v14.i1.23	Comparative effectiveness of adipose-derived mesenchymal stromal cells in the management of knee osteoarthritis: A meta-analysis	World Journal of Orthopedics	Volume 14 issue 1	Meta-Analysis	10	2904	176
11	10.3748/wjg.v29.i7.1157	Mucosal healing and inflammatory bowel disease: Therapeutic implications and new targets	World Journal of Gastroenterology	Volume 29 issue 7	Review	9	3717	245
12	10.3748/wjg.v29.i2.257	COVID-19 and liver injury: An ongoing challenge	World Journal of Gastroenterology	Volume 29 issue 2	Review	9	3376	233
13	10.3748/wjg.v29.i1.19	Microbiota of the gastrointestinal tract: Friend or foe?	World Journal of Gastroenterology	Volume 29 issue 1	Review	9	3087	233
14	10.4254/wjh.v15.i2.180	Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapy	World Journal of Hepatology	Volume 15 issue 2	Review	9	2654	193
15	10.3748/wjg.v29.i6.1054	Immunotherapy for hepatocellular carcinoma: Current status and future perspectives	World Journal of Gastroenterology	Volume 29 issue 6	Minireviews	8	3693	274
16	10.3748/wjg.v29.i16.2452	Updates on global epidemiology, risk and prognostic factors of gastric cancer	World Journal of Gastroenterology	Volume 29 issue 16	Review	8	3249	172
17	10.3748/wjg.v29.i1.126	Management of metabolic-associated fatty liver disease: The diabetology perspective	World Journal of Gastroenterology	Volume 29 issue 1	Minireviews	8	3798	251
18	10.4253/wjge.v15.i3.133	Quality of bowel preparation in patients with inflammatory bowel disease undergoing colonoscopy: What factors to consider?	World Journal of Gastrointestinal Endoscopy	Volume 15 issue 3	Minireviews	8	2057	136
19	10.12998/wjcc.v11.i3.493	Non-pulmonary involvement in COVID-19: A systemic disease rather than a pure respiratory infection	World Journal of Clinical Cases	Volume 11 issue 3	Minireviews	7	2018	137
20	10.5306/wjco.v14.i4.138	Immunotherapy in glioblastoma treatment: Current state and future prospects	World Journal of Clinical Oncology	Volume 14 issue 4	Review	7	2342	149
21	10.4254/wjh.v15.i1.1	Current therapeutic modalities and chemopreventive role of natural products in liver cancer: Progress and promise	World Journal of Hepatology	Volume 15 issue 1	Review	7	3437	292
22	10.5498/wjp.v13.i7.409	Delivering substance use prevention interventions for adolescents in educational settings: A scoping review	World Journal of Psychiatry	Volume 13 issue 7	Minireviews	7	2155	41
23	10.4330/wjc.v15.i1.13	Role of fibrinogen, albumin and fibrinogen to albumin ratio in determining angiographic severity and outcomes in acute coronary syndrome	World Journal of Cardiology	Volume 15 issue 1	Observational Study	6	2197	132
24	10.12998/wjcc.v11.i2.464	X-linked Charcot-Marie-Tooth disease after SARS-CoV-2 vaccination mimicked stroke-like episodes: A case report	World Journal of Clinical Cases	Volume 11 issue 2	Case Report	6	2019	143
25	10.3748/wjg.v29.i9.1395	Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond	World Journal of Gastroenterology	Volume 29 issue 9	Review	6	3344	209
26	10.3748/wjg.v29.i4.682	Gaseous metabolites as therapeutic targets in ulcerative colitis	World Journal of Gastroenterology	Volume 29 issue 4	Minireviews	6	3116	169
27	10.3748/wjg.v29.i11.1685	Factors affecting the quality of bowel preparation for colonoscopy in hard-to-prepare patients: Evidence from the literature	World Journal of Gastroenterology	Volume 29 issue 11	Review	6	4841	272
28	10.5306/wjco.v14.i3.99	Budd-Chiari syndrome in myeloproliferative neoplasms: A review of literature	World Journal of Clinical Oncology	Volume 14 issue 3	Review	5	3426	208
29	10.4239/wjd.v14.i5.512	Diabetes mellitus and atrial fibrillation-from pathophysiology to treatment	World Journal of Diabetes	Volume 14 issue 5	Review	5	1753	91
30	10.4239/wjd.v14.i4.396	Management of diabesity: Current concepts	World Journal of Diabetes	Volume 14 issue 4	Review	5	3501	255
31	10.4239/wjd.v14.i1.35	Future applications of exosomes delivering resolvins and cytokines in facilitating diabetic foot ulcer healing	World Journal of Diabetes	Volume 14 issue 1	Minireviews	5	2783	210
32	10.4239/wjd.v14.i1.48	Gut region-specific TNFR expression: TNFR2 is more affected than TNFR1 in duodenal myenteric ganglia of diabetic rats	World Journal of Diabetes	Volume 14 issue 1	Basic Study	5	2463	159
33	10.3748/wjg.v29.i7.1173	Choosing the best endoscopic approach for post-bariatric surgical leaks and fistulas: Basic principles and recommendations	World Journal of Gastroenterology	Volume 29 issue 7	Minireviews	5	2591	164
34	10.3748/wjg.v29.i7.1202	Comparison of genomic and transcriptional microbiome analysis in gastric cancer patients and healthy individuals	World Journal of Gastroenterology	Volume 29 issue 7	Case Control Study	5	3386	118
35	10.3748/wjg.v29.i6.908	COVID-19 and liver injury in individuals with obesity	World Journal of Gastroenterology	Volume 29 issue 6	Opinion Review	5	2809	170
36	10.3748/wjg.v29.i3.508	Artificial intelligence and inflammatory bowel disease: Where are we going?	World Journal of Gastroenterology	Volume 29 issue 3	Minireviews	5	3950	337
37	10.3748/wjg.v29.i21.3241	Emerging role of the gut microbiome in post-infectious irritable bowel syndrome: A literature review	World Journal of Gastroenterology	Volume 29 issue 21	Review	5	2715	123
38	10.3748/wjg.v29.i2.241	Liver injury in COVID-19: Clinical features, potential mechanisms, risk factors and clinical treatments	World Journal of Gastroenterology	Volume 29 issue 2	Review	5	2799	220
39	10.3748/wjg.v29.i2.272	Advancing the precision management of inflammatory bowel disease in the era of omics approaches and new technology	World Journal of Gastroenterology	Volume 29 issue 2	Review	5	2850	216
40	10.3748/wjg.v29.i18.2733	Study of tumor necrosis factor receptor in the inflammatory bowel disease	World Journal of Gastroenterology	Volume 29 issue 18	Review	5	2084	121
41	10.3748/wjg.v29.i1.157	Endoscopic ultrasound guided radiofrequency ablation for pancreatic tumors: A critical review focusing on safety, efficacy and controversies	World Journal of Gastroenterology	Volume 29 issue 1	Minireviews	5	2091	198
42	10.3748/wjg.v29.i1.43	Current status and future perspectives of radiomics in hepatocellular carcinoma	World Journal of Gastroenterology	Volume 29 issue 1	Review	5	3733	251
43	10.4251/wjgo.v15.i2.251	Is the combination of immunotherapy with conventional chemotherapy the key to increase the efficacy of colorectal cancer treatment?	World Journal of Gastrointestinal Oncology	Volume 15 issue 2	Review	5	2595	189
44	10.4251/wjgo.v15.i1.128	Risk factors, prognostic predictors, and nomograms for pancreatic cancer patients with initially diagnosed synchronous liver metastasis	World Journal of Gastrointestinal Oncology	Volume 15 issue 1	Retrospective Study	5	2172	95
45	10.4240/wjgs.v15.i4.495	Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review	World Journal of Gastrointestinal Surgery	Volume 15 issue 4	Review	5	2685	126

Among these 45 articles, 24 (53.3%) were published in World Journal of Gastroenterology, 6 (13.3%) were published in World Journal of Diabetes, 3 (6.7%) were published in World Journal of Clinical Cases, and 12 (26.7%) were published in another 8 journals.

Summary of the manuscript peer reviews

As of December 20, 2023, the 13 SCIE- and ESCI-indexed Baishideng journals received a total of 10394 peer review reports from Editorial Board Members and Peer Reviewers, accounting for an average of 1.82 (10394/5726) peer review reports per manuscript. Declines to conduct peer review of manuscripts numbered 36644.

Manuscript invitations

As of December 20, 2023, the 13 SCIE- and ESCI-indexed Baishideng journals received a total of 1859 title submissions for invited manuscripts, of which 1597 (85.9%) titles were accepted. Among the 1597 accepted invited manuscript titles, 678 manuscripts have been submitted successfully and 133 articles have been published online. For the remainder, the invited manuscripts have already been rejected or have not yet been submitted.

Journal Impact Factor™

According to the Journal Citation Reports™ released on June 28, 2023, all of the 13 SCIE- and ESCI-indexed Baishideng journals received updated Journal Impact Factors™ (JIFs).

The 7 SCIE-indexed journals: (1) World Journal of Gastroenterology, JIF: 4.3; (2) World Journal of Diabetes, JIF: 4.2; (3) World Journal of Stem Cells, JIF: 4.1; (4) World Journal of Psychiatry, JIF: 3.1; (5) World Journal of Gastrointestinal Oncology, JIF: 3.0; (6) World Journal of Gastrointestinal Surgery, JIF: 2.0; and (7) World Journal of Clinical Cases, JIF: 1.1.

The 6 ESCI-indexed journals: (1) World Journal of Clinical Oncology, JIF: 2.8; (2) World Journal of Radiology, JIF: 2.5; (3) World Journal of Hepatology, JIF: 2.4; (4) World Journal of Gastrointestinal Endoscopy, JIF: 2.0; (5) World Journal of Cardiology, JIF: 1.9; and (5) World Journal of Orthopedics, JIF: 1.9.

POLICY CHANGES AND POLICY ADDITIONS RELATED TO BAISHIDENG JOURNALS IN 2023

Publishing partners

In 2023, well-known institutions in China were carefully chosen for invitation to become publishing partners for Baishideng journals, six of which successfully completed the joint vetting process and formally partnered with five Baishideng journals. These respected institutions include Shanghai Pancreatic Cancer Institute and Pancreatic Cancer Institute of Fudan University, and Biliary Tract Disease Institute of Fudan University partnering with World Journal of Gastroenterology. Each of these six new publishing partners will help Baishideng to better promote the development of Baishideng journals, while Baishideng will help these publishing partners to enhance their international academic cooperation and exchange activities, strengthening their academic reputations nationally and extending them worldwide.

Manuscript initial submission

Starting in August 2023, the process of initial submission was updated so that authors can conveniently make the first upload of their manuscript without restrictions on writing style, file format, or need for accompanying relevant documents. This enables authors to submit their manuscripts faster, ultimately attracting more authors to submit their manuscripts to Baishideng journals. The updated guidelines for authors can be found at https://www.wjgnet.com/bpg/gerinfo/204.

Co-authors policy

To acknowledge the evolution of research towards equal contributions among broader groups of researchers, in August 2023 Baishideng initiated allowance of co-first authorship and co-corresponding authorship. Co-first authors and co-corresponding authors are now formally cited in a footnote for manuscripts published in Baishideng journals. The detailed co-authorship policy can be found at: https://www.wjgnet.com/bpg/GerInfo/310.

Article Processing Charge policy

To better acknowledge the contributions by Editorial Board Members and Peer Reviewers, and to help authors from low- and middle-income countries, in December 2023 Baishideng updated its Article Processing Charge (APC) policy. If an unsolicited manuscript has a corresponding author who is a member of the Editorial Board or serves as a Peer Reviewer for Baishideng journals, the APC will be reduced by 50% (previously 10%), and Baishideng will provide discounts in line with the Research4Life Programme (https://www.research4life.org/access/eligibility/) as follows: Group A countries will receive full waiver of the APC; and Group B countries will receive a 50% discount. For the detailed policy of APC, please visit: https://www.wjgnet.com/bpg/gerinfo/242.

Reference Citation Analysis

Starting in April 2023, Reference Citation Analysis (RCA), a unique artificial intelligence system for citation index evaluation of literature, sharpened its focus onto the medical sciences and life sciences literature. As of December 20, 2023, a total of 54375058 articles and 6129 quality journals encompassing 124 categories are indexed in RCA. Meanwhile, 4039 scholars from countries across the globe registered as RCA scholars, and 48981 subscribers subscribed to RCA. For more information about RCA, please visit: https://www.referencecitationanalysis.com/.

UNIQUE ADVANTAGES OF BAISHIDENG JOURNALS

Manuscript publication processing time

In general, for most of the manuscripts submitted to any Baishideng journal, the first decision/peer review procedure can be done within 28 d from the date that the journal receives the manuscript; other than this, the maximum time will not exceed 90 d. Moreover, most accepted papers can be published online within 20 d; other than this, the maximum time will not exceed 30 d.

Control of academic quality

To control the academic quality of Baishideng journals’ manuscripts, all Editorial Board Members are invited to participate in the second decision process. In addition, all Editorial Board Members are invited to write editorials on accepted articles that are ready to be published, to expand their academic impact.

Control of language quality

To control the language quality of Baishideng journals’ published articles, from January to November 2023, more than 760 manuscripts were edited by our language Editors, and Baishideng paid nearly $40000 for this.

Fight against plagiarism

To fight against plagiarism and to ensure high ethical standards for all of the published articles, Baishideng joined iThenticate (CrossCheck) in 2014. iThenticate is an effective tool for detecting unoriginal content, enabling our editors to preserve our journals’ integrity and authors’ copyright. For all accepted manuscripts, we will conduct iThenticate detection. If a significant amount of overlapping text (e.g., overlap > 5% or similarity > 50%) is found, we will immediately verify if the manuscript is associated with plagiarism. Once plagiarism is confirmed, the manuscript will be rejected immediately and all authors of the manuscript will be included in the black-list of Baishideng journals.

Ethical requirements

For all manuscripts involving animal/human experiments, author(s) must submit the related formal ethics documents that were reviewed and approved by their local ethical review committee. The approved ethics document(s) will be released online, together with the manuscript. This is why none of the articles published in Baishideng journals were retracted due to academic misconduct in 2022-2023. This practice not only effectively improves the reliability of articles published in Baishideng journals but also helps to eliminate articles from “Fake-Paper Factories”.

Authors/Editorial Board Members’ evaluation and Readers’ comments

After an article is published in any Baishideng journal, the authors are invited to evaluate their experience with the article publishing process, the Editorial Board Members are invited to further track and evaluate the scientific and linguistic quality of the article, and the readers in the relevant field are invited to comment on the article. As of December 20, 2023, a total of 2409 authors’ evaluations and 1999 Editorial Board Members’ evaluations have been received by the Baishideng journals for the year. From September to December 2023, a total of 78 readers’ comments have been received by the Baishideng journals.

CONCLUSION

Finally, we hope that more researchers/authors will continue to submit high-quality manuscripts to Baishideng journals in 2024, and all Editorial Board Members/Peer Reviewers will continue to conduct high-quality peer review for Baishideng journals in 2024, and support Baishideng to publish more high-quality articles that will make substantive contributions to the development of clinical and basic medical research.